Research Article

Changes of circulating CD4+CD25+CD127low regulatory T cells in patients with acute coronary syndrome and its significance

Published: December 07, 2015
Genet. Mol. Res. 14 (4) : 15930-15936 DOI: https://doi.org/10.4238/2015.December.7.4
Cite this Article:
M. Liu, L.J. Xu, J.X. Wu (2015). Changes of circulating CD4+CD25+CD127low regulatory T cells in patients with acute coronary syndrome and its significance. Genet. Mol. Res. 14(4): 15930-15936. https://doi.org/10.4238/2015.December.7.4
2,801 views

Abstract

The aim of this study was to investigate the changes of circulating CD4+CD25+CD127low regulatory T cells (Treg) in patients with acute coronary syndrome (ACS) and its significance. The experiment was divided into three groups: ACS (48 patients), stable angina pectoris (SAP) (24 patients), and normal controls (24 subjects). The CD4+CD25+CD127low Treg cell counts were tested by flow cytometry, and the levels of high-sensitivity C-reactive protein (hs-CRP) and peripheral blood leukocytes (PWBCs) were determined in the peripheral blood of each group; comparisons were made among groups. The frequency of CD4+CD25+CD127low to CD4+ cell in the ACS group (3.18 ± 1.76%) was significantly lower than those observed in control (5.64 ± 1.63%) and SAP (5.60 ± 1.56%) groups (F = 25.247, P < 0.01), while the hs-CRP and PWBC levels in the ACS group were significantly higher than those in the control group (P < 0.05). In addition, the reduced frequency of CD4+CD25+CD127low to CD4+ cells was negatively correlated with the increased hs-CRP and PWBC counts by correlation analysis, and the related coefficients (r) were -0.518 and -0.311, respectively (P < 0.01). These findings indicate that the decrease of the frequency of Treg cells in the peripheral blood of patients with ACS might destroy the balance of tolerance of the peripheral immune system and might activate inflammation, thus participating in the occurrence and development of the pathological processes of atherosclerosis.

The aim of this study was to investigate the changes of circulating CD4+CD25+CD127low regulatory T cells (Treg) in patients with acute coronary syndrome (ACS) and its significance. The experiment was divided into three groups: ACS (48 patients), stable angina pectoris (SAP) (24 patients), and normal controls (24 subjects). The CD4+CD25+CD127low Treg cell counts were tested by flow cytometry, and the levels of high-sensitivity C-reactive protein (hs-CRP) and peripheral blood leukocytes (PWBCs) were determined in the peripheral blood of each group; comparisons were made among groups. The frequency of CD4+CD25+CD127low to CD4+ cell in the ACS group (3.18 ± 1.76%) was significantly lower than those observed in control (5.64 ± 1.63%) and SAP (5.60 ± 1.56%) groups (F = 25.247, P < 0.01), while the hs-CRP and PWBC levels in the ACS group were significantly higher than those in the control group (P < 0.05). In addition, the reduced frequency of CD4+CD25+CD127low to CD4+ cells was negatively correlated with the increased hs-CRP and PWBC counts by correlation analysis, and the related coefficients (r) were -0.518 and -0.311, respectively (P < 0.01). These findings indicate that the decrease of the frequency of Treg cells in the peripheral blood of patients with ACS might destroy the balance of tolerance of the peripheral immune system and might activate inflammation, thus participating in the occurrence and development of the pathological processes of atherosclerosis.

About the Authors